16 Oct 2009

Optimising Care for Patients with Head and Neck Cancer Forum

Share this page Email this page to a friend Share this page via Twitter Share this page via Facebook Share this page via LinkedIn

This multidisciplinary education day was designed for all health professionals interested in or working with patients with head and neck cancer, including: medical officers and general practitioners, nursing and allied health professionals. The program covered aspects of the patient journey from signs, symptoms and referral pathways, radiotherapy and surgical techniques, the role of chemotherapy, PEG and tracheotomy and included patient and palliative perspectives.

The patient perspective

Noeline Hunt
Noelene Hunt

In April 2007, Noelene Hunt was diagnosed with a nasopharyngeal carcinoma and was treated with chemotherapy and radiotherapy at the Sydney Head and Neck Cancer Clinic. As the first speaker of the forum, Noelene presented her personal journey as a head and neck cancer patient to set the scene of 'patient focussed care'. Noelene's session was rated as the most enjoyed aspect of the day.

Signs, symptoms and referral pathways

Dr Kerwin Shannon, Director, Sydney Head and Neck Cancer Institute; Head and Neck Surgeon, Chair NSWOG Head and Neck
Kerwin Shannon

This introductory session explained the epidemiology, risk factors and head and neck tumour characteristics as well as referral pathways and data on referral delays.

Surgical techniques

Dr Carsten Palme, Head and Neck Surgeon, Westmead Hospital
Carsten Palme

Using video presentations, Dr Carsten Palme demonstrated the use of laser microsurgery for early laryngeal cancer. The presentation included background information to the procedure, a description the requirements when setting up Endoscopic Laser Service and the clinical results and experience of using the technique at Westmead Hospital.?

Patterns of patient information needs and affective distress for people with head and neck cancer and their family members

Luci Dall'Armi, Head and Neck Cancer Nurse Co-ordinator, Liverpool Hospital
Head and neck resource

This presentation outlined results of the Cancer Institute NSW funded project designed to address the information needs of head and neck cancer patients. The study found limited appropriate resources in the Australian context and that patients and families were most interested in information regarding disease and survivorship.

Role of chemotherapy in head and neck cancer

Professor Michael Boyer, Medical Oncologist Sydney Cancer Centre
Michael Boyer

Professor Michael Boyer described the Role of Systemic Therapy in Head and Neck Cancer, outlining systemic agents used, toxicity relating to each and incorporating chemotherapy with loco-regional therapy. There was a brief outline of research and trials combining different chemotherapy agents with radiation therapy and overall survival outcomes.

Radiotherapy techniques

Dr Allan Fowler, Radiation Oncologist, SSWAHS
Alan Fowler

The role of radiotherapy for head and neck patients was explored in this session, specifically the process of delivering radiotherapy, the dose, planning and defining gross tumour volumes. This session briefly provided an overview of the common side effects of radiation therapy.

Oral complications of head and neck cancer treatment

Dr Sue-Ching Yeoh, Specialist, Oral Medicine & Oral Pathology, SSWAHS
Dr Claire Scott, Senior Dental Officer, Royal Prince Alfred Dental Clinic

Radiation Caries

Oral and dental complications of head and neck cancer treatments were described in detail, particularly those resulting from radiation therapy. These side effects include mucositis, xerostomia, loss of taste and radiation caries. The presentation also detailed the effect of trismus, fibrosis and irradiated bone as well as practical strategies to combat these side effects.

  1. Returning home after hospital treatment
  2. Returning to work in a position you like
  3. Earning money
  4. Getting around - when is it safe to drive again?
  5. Spending time with friends

Speech and swallowing issues

Julia Maclean, Speech Pathologist, St George Hospital

Julia Maclean

Using video case studies, Julie Maclean demonstrated how swallowing assessment is conducted and swallowing therapy and strategies to maintain function. The session also provided an overview of communication and voice disorders related to alteration of head and neck anatomy.

Nutritional challenges for patients with head and neck cancer



Merran Findlay, Senior Oncology Dietitian, Royal Prince Alfred

Merran Findlay

This session highlighted the importance of nutrition intervention before, during and after treatment with continued access to services. Using case studies to demonstrate the evidence of benefit, the presentation also included an overview of nutrition assessment and post-treatment monitoring.

Caring for tracheostomy and PEG at home

Justine Oates, Head and Neck Cancer Care Coordinator, Royal Prince Alfred

Justine Oates

This detailed session provided a comprehensive overview of the functional aspects of tracheostomy and PEG tubes; their design and function, challenges and complications and appropriate care requirements.

Palliative care perspectives

Joan Ryan, Palliative Care Clinical Nurse Consultant, Royal Prince Alfred

Joan Ryan

With emphasis on providing dignity and autonomy in end of life care, this session described the complexities and unique factors impacting on patients with head and neck cancer, a highly symptomatic population with an alienating disease.

The day closed with a question and answer session with an expert panel, which included speakers from the afternoon sessions.

Q and A

A/Professor Andrew Cole

Rehabilitation: Applying rehabilitation therapies to improve quality of life and functional therapies

Event details and registration

Date/Time 16 Oct 2009

Please note:
Events publicised on this website align to the goals and objectives of the NSW Cancer Plan 2011-2015, are evidence-based, not-for profit and are conducted by:

  • Professional colleges
  • Cancer councils
  • State-based, national and international cancer control organisations and agencies.
  • Cancer or health services
  • Government organisations
  • Academic institutions.

The Cancer Institute NSW will consider events that meet this criteria on a case-by-case basis, and will not support activities or groups that do not comply with strict evidence-based principles.

Top of page